Clinical Trial Update: Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

View source ↗

Summary

This entry notes a clinical trial evaluating the HER2DX assay to influence treatment decisions in early-stage HER2-positive breast cancer; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Status: RECRUITING